Clinical Trial

An Observational Study of Patients With Metabolic Syndrome and Related Conditions

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
TARGET-METABOLIC is an observational research study to conduct a comprehensive review of outcomes for patients with metabolic syndrome and related conditions.
Trial Details
NCT Number NCT05842811
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Metabolic Syndrome
Enrollment 2,000,000 participants
Start Date 2023-05-24
Primary Completion 2038-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-05-06